Regional vascular responses to ATP and ATP analogues in the rabbit kidney in vivo: Roles for adenosine receptors and prostanoids

British Journal of Pharmacology

Volumn 149, Issue 5, 2006, Pages 523-531

  Eppel, G A ^a   Ventura, S ^a   Evans, R G ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

, methylene ATP; , methylene ATP; 8 (psulphophenyl)theophylline; Adenosine; ATP; Ibuprofen; NO; Purinoceptors; Renal circulation; Renal medulla

Indexed keywords

8 (4 SULFOPHENYL)THEOPHYLLINE; ADENOSINE; ADENOSINE RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE TRIPHOSPHATE; ADENOSINE TRIPHOSPHATE DERIVATIVE; ALPHA,BETA METHYLENEADENOSINE TRIPHOSPHATE; BETA,GAMMA METHYLENEADENOSINE TRIPHOSPHATE; IBUPROFEN; N(G) NITROARGININE; PENTOBARBITAL; PROSTANOID; PURINE P2 RECEPTOR; PURINERGIC RECEPTOR STIMULATING AGENT;

ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG INHIBITION; HEART RATE; HYPEREMIA; ISCHEMIA; KIDNEY BLOOD FLOW; KIDNEY CIRCULATION; KIDNEY CORTEX; KIDNEY VASCULAR RESISTANCE; LASER DOPPLER FLOWMETRY; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ADENOSINE; ADENOSINE TRIPHOSPHATE; ANIMALS; CYCLOOXYGENASE INHIBITORS; IBUPROFEN; KIDNEY; KIDNEY CORTEX; KIDNEY MEDULLA; LASER-DOPPLER FLOWMETRY; MALE; NITRIC OXIDE SYNTHASE; NITROARGININE; PROSTAGLANDINS; RABBITS; RECEPTORS, PURINERGIC P1; RECEPTORS, PURINERGIC P2; REGIONAL BLOOD FLOW; RENAL CIRCULATION; THEOPHYLLINE;

EID: 33750475200     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706901     Document Type: Article

References (37)

1. Bailey SJ, Hourani SM (1990). A study of the purinoceptors mediating contraction in the rat colon. Br J Pharmacol 100: 753-756.
2. Chan CM, Unwin RJ, Bardini M, Oglesby IB, Ford AP, Townsend-Nicholson A et al. (1998). Localization of P2X1 purinoceptors by autoradiography and immunohistochemistry in rat kidneys. Am J Physiol Renal Physiol 274: F799-F804.
3. Chen CC, Akopian AN, Sivilotti L, Colquhoun D, Burnstock G, Wood JN (1995). A P2X purinoceptor expressed by a subset of sensory neurons. Nature 377: 428-431.
4. Daly JW, Padgett W, Shamim MT, Butts-Lamb P, Waters J (1985). 1,3-Dialkyl-8-(p-sulfophenyl)xanthines: potent water-soluble antagonists for A1- and A2-adenosine receptors. J Med Chem 28: 487-492.
5. Denton KM, Anderson WP (1994). Intrarenal haemodynamic and glomerular responses to inhibition of nitric oxide formation in rabbits. J Physiol (London) 475: 159-167.
6. Eppel GA, Bergström G, Anderson WP, Evans RG (2003a). Autoregulation of renal medullary blood flow in rabbits. Am J Physiol Regul Integr Comp Physiol 284: R233-R244.
7. Eppel GA, Denton KM, Malpas SC, Evans RG (2003b). Nitric oxide in responses of regional kidney perfusion to renal nerve stimulation and renal ischaemia. Pflügers Arch - Eur J Physiol 447: 205-213.
8. Eppel GA, Lee LL, Evans RG (2004). α-Adrenoceptor subtypes mediating regional kidney blood flow responses to renal nerve stimulation. Auton Neurosci Basic Clin 112: 15-24.
9. Eppel GA, Ventura S, Denton KM, Evans RG (2006). Lack of contribution of P2X receptors to neurally mediated vasoconstriction in the rabbit kidney in vivo. Acta Physiol 186: 197-207.
10. Evans RG, Eppel GA, Anderson WP, Denton KM (2004). Mechanisms underlying the differential control of blood flow in the renal medulla and cortex. J Hypertens 22: 1439-1451.
11. Evans RG, Rankin AJ, Anderson WP (1994). Interactions of blockade of nitric oxide synthase and angiotensin-converting enzyme on renal function in conscious rabbits. J Cardiovasc Pharmacol 24: 542-551.
12. Evans RJ, Lewis C, Buell G, Valera S, North RA, Surprenant A (1995). Pharmacological characterization of heterologously expressed ATP-gated cation channels (P2x purinoceptors). Mol Pharmacol 48: 178-183.
13. Hansen PB, Hashimoto S, Oppermann M, Huang Y, Briggs JP, Schnermann J (2005). Vasoconstrictor and vasodilator effects of adenosine in the mouse kidney due to preferential activation of A1 or A2 adenosine receptors. J Pharmacol Exp Ther 315: 1150-1157.
14. Hourani SM, Bailey SJ, Nicholls J, Kitchen I (1991). Direct effects of adenylyl 5′-(beta,gamma-methylene)diphosphonate, a stable ATP analogue, on relaxant P1-purinoceptors in smooth muscle. Br J Pharmacol 104: 685-690.
15. Inscho EW (2001). P2 receptors in regulation of renal microvascular function. Am J Physiol Renal Physiol 280: F927-F944.
16. Inscho EW, Cook AK, Imig JD, Vial C, Evans RJ (2003). Physiological role for P2X1 receptors in renal microvascular autoregulatory behavior. J Clin Invest 112: 1895-1905.
17. Jackson EK, Zhu C, Tofovic SP (2002). Expression of adenosine receptors in the preglomerular microcirculation. Am J Physiol Renal Physiol 283: F41-F51.
18. Kalyan A, Eppel GA, Anderson WP, Oliver JJ, Evans RG (2002). Renal medullary interstitial infusion is a flawed technique for examining vasodilator mechanisms in anesthetized rabbits. J Pharmacol Toxicol Methods 47: 153-159.
19. Kerstan D, Gordjani N, Nitschke R, Greger R, Leipziger J (1998). Luminal ATP induces K + secretion via a P2Y2 receptor in rat distal colonic mucosa. Pflügers Arch - Eur J Physiol 436: 712-716.
20. Kunapuli SP, Daniel JL (1998). P2 receptor subtypes in the cardiovascular system. Biochem J 336: 513-523.
21. Lewis CJ, Evans RJ (2001). P2X receptor immunoreactivity in different arteries from the femoral, pulmonary, cerebral, coronary and renal circulations. J Vasc Res 38: 332-340.
22. Liu M, King BF, Dunn PM, Rong W, Townsend-Nicholson A, Burnstock G (2001). Coexpression of P2X(3) and P2X(2) receptor subunits in varying amounts generates heterogeneous populations of P2X receptors that evoke a spectrum of agonist responses comparable to that seen in sensory neurons. J Pharmacol Exp Ther 296: 1043-1050.
23. Ludbrook J (1994). Repeated measurements and multiple comparisons in cardiovascular research. Cardiovasc Res 28: 303-311.
24. Ludbrook J (1998). Multiple comparison procedures updated. Clin Exp Pharmacol Physiol 25: 1032-1037.
25. Majid DS, Inscho EW, Navar LG (1999). P2 purinoceptor saturation by adenosine triphosphate impairs renal autoregulation in dogs. J Am Soc Nephrol 10: 492-498.
26. Malmström RE, Björne H, Alving K, Weitzberg E, Lundberg JO (2001). Nitric oxide inhibition of renal vasoconstrictor responses to sympathetic cotransmitters in the pig in vivo. Nitric Oxide 5: 98-104.
27. Nishiyama A, Inscho EW, Navar LG (2001). Interactions of adenosine A1 and A2a receptors on renal microvascular reactivity. Am J Physiol Renal Physiol 280: F406-F414.
28. Norenberg W, Illes P (2000). Neuronal P2X receptors: localisation and functional properties. Naunyn Schmiedebergs Arch Pharmacol 362: 324-339.
29. Nori S, Fumagalli L, Bo X, Bogdanov Y, Burnstock G (1998). Coexpression of mRNAs for P2X1, P2X2 and P2X4 receptors in rat vascular smooth muscle: an in situ hybridization and RT-PCR study. J Vasc Res 35: 179-185.
30. North RA, Surprenant A (2000). Pharmacology of cloned P2X receptors. Annu Rev Pharmacol Toxicol 40: 563-580.
31. Ralevic V, Burnstock G (1998). Receptors for purines and pyrimidines. Pharmacol Rev 50: 413-492.
32. Rump LC, Jabbari TJ, Von Kugelgen I, Oberhauser V (1999). Adenosine mediates nitric-oxide-independent renal vasodilation by activation of A2A receptors. J Hypertens 17: 1987-1993.
33. Snedecor GW, Cochran WG (1967). Statistical Methods. The Iowa State University Press: Ames, Iowa.
34. Wang L, Karlsson L, Moses S, Hultgardh-Nilsson A, Andersson M, Borna C et al. (2002). P2 receptor expression profiles in human vascular smooth muscle and endothelial cells. J Cardiovasc Pharmacol 40: 841-853.
35. Wangensteen R, Fernandez O, Sainz J, Quesada A, Vargas F, Osuna A (2000). Contribution of endothelium-derived relaxing factors to P2Y-purinoceptor- induced vasodilation in the isolated rat kidney. Gen Pharmacol 35: 129-133.
36. Webb TE, Simon J, Krishek BJ, Bateson AN, Smart TG, King BF et al. (1993). Cloning and functional expression of a brain G-protein-coupled ATP receptor. FEBS Lett 324: 219-225.
37. Yamamoto K, Sokabe T, Matsumoto T, Yoshimura K, Shibata M, Ohura N et al. (2006). Impaired flow-dependent control of vascular tone and remodeling in P2X4-deficient mice. Nat Med 12: 133-137.